SPL 2.11% 9.3¢ starpharma holdings limited

Ann: DEP docetaxel and gemcitabine combination trial commences, page-2

  1. 15,510 Posts.
    lightbulb Created with Sketch. 5586
    So does this mean they are saving bigger news for the Quarterly ? Two nothing much announcements this week, which could have formed part of the Quarterly IMO - perhaps they didn't want to detract from whatever is in it so they are getting these minor announcements out of the way to leave the focus on something bigger ? I guess I can dream ...
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.